Category: Regulatory

340B Health Centers Appeal Loss in California Medicaid Lawsuit

September 14, 2023 Rich Daly, Editor in Chief Views

Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.

California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

September 14, 2023 Rich Daly, Editor in Chief Views

The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.

Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Can Enforce 340B Contract Pharmacy Law, State Attorney Tells Appeals Court

September 12, 2023 William Newton, Associate Editor/Senior Writer Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

An attorney for the state of Arkansas recently told a federal appeals court that the state will enforce its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Allows Immediate 340B Enrollment in Florida Due to Hurricane

September 8, 2023 Rich Daly, Editor in Chief Views

HRSA updated 340B enrollment eligibility guidelines in Florida in response to a public health emergency for Hurricane Idalia.

Eligible covered entities in Florida may enroll in the 340B program immediately rather than having to wait for the next [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

As CMS Extends Comment Period on 340B Repayments, Hospitals Urge Changes

September 6, 2023 Rich Daly, Editor in Chief Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

While federal regulators recently extended the comment period on a proposed lump sum repayment plan for hospitals Illegally underpaid for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Again Selects Bizzell Group to Audit 340B Covered Entities

August 31, 2023 Tom Mirga, Editor at Large Views

Dr. Anton Bizzell is president and CEO of The Bizzell Group, which recently signed a contract with HRSA to continue auditing 340B covered entities.

The Health Resources and Services Administration (HRSA) has awarded a $25.3 million, five-year contract to The Bizzell Group to audit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Announces First 10 Drugs Eligible for Medicare Price Negotiations

August 29, 2023 William Newton, Associate Editor/Senior Writer Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

The Department of Health and Human Services (HHS) today announced the first 10 prescription drugs eligible for Medicare price negotiations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

August 24, 2023 Rich Daly, Editor in Chief Views

340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.

Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Maker Owes 340B Providers Repayment, HRSA Pending Audit Finds

August 22, 2023 Rich Daly, Editor in Chief Views

A HRSA fiscal year 2023 audit tentatively found that drug maker Nephron Pharmaceuticals owes 340B repayments to providers.

The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Drugs Among Those at Tornado-Hit Facility Requiring Direct Purchase

August 22, 2023 Rich Daly, Editor in Chief Views

Pfizer has limited multiple 340B-eligible drugs to direct purchase after a tornado damaged one of the drug maker's manufacturing facilities.

Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live